Novolog (Pharm-Up 1966) Ltd
NVLG.TA
Price:
$127.1
Market Cap:
$649.32M
Novolog (Pharm-Up 1966) Ltd provides healthcare services in Israel. It offers medical devices to healthcare institutions and patients in their homes; and medical logistics services to pharmaceutical and medical device companies. The company also produces and disseminates medical content and tools to the general public and medical community; and develops personalized treatment programs and initiates home visits by nurses. In addition, it provides health and medical process management services for corporations; and supplies sterilization services using ethylene oxide gas for medical and laboratory products, as well as offers direct access to health and wellness ecosystem for international corp...[Read more]
Industry
Medical - Care Facilities
IPO Date
2017-02-28
Stock Exchange
TLV
Ticker
NVLG.TA
PE Ratio
[63.55]
ROE
[5.06%]
Current Ratio
[0.96]
Dividend Yield
[3.08%]
Enterprise Value
[621.26M]
Dividend History
The ROE as of December 2025 (TTM) for Novolog (Pharm-Up 1966) Ltd (NVLG.TA) is 5.06%
According to Novolog (Pharm-Up 1966) Ltd’s latest financial reports and current stock price. The company's current ROE is 5.06%. This represents a change of 303.40% compared to the average of 1.26% of the last 4 quarters.
Novolog (Pharm-Up 1966) Ltd (NVLG.TA) Historical ROE (quarterly & annually)
How has NVLG.TA ROE performed in the past?
The mean historical ROE of Novolog (Pharm-Up 1966) Ltd over the last ten years is 15.19%. The current 5.06% ROE has changed -66.65% with respect to the historical average. Over the past ten years (40 quarters), NVLG.TA's ROE was at its highest in in the September 2016 quarter at 9.42%. The ROE was at its lowest in in the December 2023 quarter at -11.73%.
Average
15.19%
Median
12.25%
Minimum
-11.32%
Maximum
41.20%
Novolog (Pharm-Up 1966) Ltd (NVLG.TA) ROE by Quarter and Year
Discovering the peaks and valleys of Novolog (Pharm-Up 1966) Ltd ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 253.80%
Maximum Annual ROE = 41.20%
Minimum Annual Increase = -203.87%
Minimum Annual ROE = -11.32%
| Year | ROE | Change |
|---|---|---|
| 2024 | 10.73% | -194.82% |
| 2023 | -11.32% | -203.87% |
| 2022 | 10.90% | 9.28% |
| 2021 | 9.97% | -26.66% |
| 2020 | 13.60% | 253.80% |
| 2019 | 3.84% | -82.14% |
| 2018 | 21.51% | -18.02% |
| 2017 | 26.24% | -36.31% |
| 2016 | 41.20% | 63.57% |
| 2015 | 25.19% | -9.15% |
Novolog (Pharm-Up 1966) Ltd (NVLG.TA) Average ROE
How has NVLG.TA ROE performed in the past?
The current ROE of Novolog (Pharm-Up 1966) Ltd (NVLG.TA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.44%
5-year avg
6.78%
10-year avg
15.19%
Novolog (Pharm-Up 1966) Ltd (NVLG.TA) ROE vs. Peers
How is NVLG.TA’s ROE compared to its peers?
Novolog (Pharm-Up 1966) Ltd’s ROE is less than Ilex Medical Ltd (6.64%), greater than Golden House Ltd (-2.10%), greater than Compugen Ltd. (-34.77%), less than Bait Bakfar Ltd (9.99%), greater than Merchavia Holdings and Investments Ltd. (-80.35%), greater than BATM Advanced Communications Ltd. (-26.71%), greater than Oramed Pharmaceuticals Inc. (-16.16%), less than Pulsenmore Ltd. (1.79%), less than BrainsWay Ltd. (8.97%), greater than InterCure Ltd. (-17.13%),
| Company | ROE | Market cap |
|---|---|---|
| 6.64% | $748.60M | |
| -2.10% | $172.23M | |
| -34.77% | $455.24M | |
| 9.99% | $1.02B | |
| -80.35% | $41.07M | |
| -26.71% | $302.72M | |
| -16.16% | $392.08M | |
| 1.79% | $166.97M | |
| 8.97% | $1.03B | |
| -17.13% | $224.30M |
Build a custom stock screener for Novolog (Pharm-Up 1966) Ltd (NVLG.TA) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Novolog (Pharm-Up 1966) Ltd using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Novolog (Pharm-Up 1966) Ltd (NVLG.TA) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Novolog (Pharm-Up 1966) Ltd or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Novolog (Pharm-Up 1966) Ltd's ROE?
How is the ROE calculated for Novolog (Pharm-Up 1966) Ltd (NVLG.TA)?
What is the highest ROE for Novolog (Pharm-Up 1966) Ltd (NVLG.TA)?
What is the 3-year average ROE for Novolog (Pharm-Up 1966) Ltd (NVLG.TA)?
What is the 5-year average ROE for Novolog (Pharm-Up 1966) Ltd (NVLG.TA)?
How does the current ROE for Novolog (Pharm-Up 1966) Ltd (NVLG.TA) compare to its historical average?